Sensus Healthcare Bolsters Senior Management Team

Sensus Healthcare Inc. has strengthened its management team with various promotions and appointments. 

The company has promoted Maggie Martinez to chief operating officer (COO), Emiliano Sosa to chief technical officer, and Stephanie Tipton to vice president of Marketing. In addition, Sensus Healthcare has hired Sean Delaney as vice president of Regulatory and Quality Assurance, and Wayne Lura as vice president of Aesthetic sales.

“Our history of growth, execution and expanding market opportunities have made these staff changes both necessary and prudent, including creating several new positions. I am delighted to announce these promotions and appointments and look forward to the contributions of these talented individuals as Sensus executes on an aggressive business strategy,” Sensus Healthcare Chairman/CEO Joe Sardano said. “Maggie Martinez has proven over and over again her initiative, drive and commitment to the company, our customers and patients and I am proud of her appointment to chief operating officer. In just a short period of time, Emiliano Sosa has distinguished himself in assembling a high-quality team of engineers who are adding exceptional value to our technologies.  His leadership skills and technical acumen ideally qualify him to serve as our chief technical officer. Stephanie Tipton has been a creative force in digital marketing for the company, and going forward she is charged with assuming a leadership role in all aspects of marketing.  She will be instrumental in supporting the introduction of new products to the marketplace, an important initiative for Sensus.”
 
Martinez joined Sensus nine years ago and subsequently held positions of increasing responsibility.  Most recently she served as vice president of Operations, and in her new role as COO she will be responsible for all aspects of customer support and satisfaction, vendor relations, intra-company communication and processes. Martinez earned a bachelor of science degree in marketing from Stetson University in DeLand, Fla.
 
Sosa joined Sensus last year as vice president of Technology Development with extensive experience in banking, cybersecurity, and artificial intelligence. Among his accomplishments are  the introduction and engineering of the first GPS device in the Argentina market with real time streaming video cameras for vehicles (founding Overmax S.A.). His company in the U.S. was recognized as 2016 small business of the year. He has also designed and developed electroencephalography and brain mapping devices, implementing the first 3-D EEG Brain Mapping medical devices and polysomnographs at the time. In his new position he is charged with overseeing and expanding the company’s team of engineers to provide dependable and differentiated technologies to customers and their patients. A priority focus will be on expanding the capabilities and indications of the company’s Sentinel technology. Sentinel provides asset management and HIPAA-compliant patient data and storage capability, and also contains the software necessary to support shared service models including direct patient billing. Sosa earned degrees in information systems engineering from the National University of Technology in Buenos Aires, and in international marketing and foreign trade from the University of Buenos Aires in Argentina.
 
Tipton joined Sensus in June of 2021 as director of Digital Marketing, revamping the company’s social media and on-line outreach, which resulted in a dramatic increase in patient and physician inquiries. She has also worked closely with the company’s clinical, sales, and engineering teams to provide a more comprehensive approach to the product portfolio. As an experienced marketing professional with a record of success, she was president of Tipton Group, a marketing consulting firm prior to joining Sensus.  Previously she was for six years Industrial Director/director of Sales for Nova Medical Centers in Knoxville, Tenn. Tipton earned a bachelor of science degree in biology and business administration from the University of Tennessee, Knoxville.
 
Delany brings to Sensus nearly 20 years of product development experience in regulatory affairs, quality assurance and regulatory compliance, including worldwide regulatory clearances and approvals, development and product quality, international standard compliance and post–market surveillance. Much of his experience is in software-controlled image-guided radiation therapy systems. Most recently, Delaney worked at ViewRay, with responsibility for regulatory affairs and compliance, quality assurance, radiation safety, and U.S. Food and Drug Administration submissions. He earned a bachelor of science degree in physics from San Jose State University and an MBA from Santa Clara University, Leavey School of Business.
 
Lura has two decades of experience in medical aesthetics, bringing new products to market at such notable companies as Cynosure, Eclipse Medical, DefenAge Skincare, Zimmer Medical Systems, Cutera, and Lumenis. He is responsible for expanding Sensus’ aesthetics footprint as the company continues to add to its product portfolio, and developing opportunities for product introductions including developing a total solution bundle for Sensus customers. Lura brings to Sensus deep relationships with industry key opinion leaders and dermatologists. He earned a bachelor of arts degree in communications from Concordia University Texas, attended the United States Air Force Academy, and was a commissioned Second Lieutenant in the Air Force ROTC at the University of Texas, Austin. 
 
“Our anticipated growth has necessitated the expansion of our senior management team. I’m thrilled Sean Delany has joined Sensus as vice president of Regulatory and Quality Assurance. Sean comes to us with deep experience navigating regulatory pathways not only in the U.S., but in all of Asia, the EU and South America,” Sardano stated. “His knowledge will be valuable as we work to secure regulatory clearances for our products—both existing and new—around the world. Additionally, we look forward to even greater success with our growing aesthetics product portfolio with Wayne Lura at the helm. His appointment underscores our plans to expand our aesthetic footprint with innovative products. Wayne has a wealth of contacts and enjoys excellent relationships with the leaders in aesthetic medicine. Our goal is for Sensus to be a destination for great employees from all walks of life and backgrounds. I am proud of our workforce, all contributing to our success with an unwavering commitment to quality, innovation, teamwork, respect and customer service.” 
 
Sensus Healthcare Inc. is a medical device company specializing in non-invasive, minimally invasive, and cost-effective treatments for both oncological and non-oncological conditions. Sensus offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of R&D, to treat non-melanoma skin cancers and keloids with its SRT-100, SRT-100+ and SRT-100 Vision systems.